Company: ATRA
Filing Date: 2025-03-07
Form Type: 10-K
Source: 0000950170-25-035507
Chunk: 0

Company: Atara Biotherapeutics, Inc.
Filing Date: 2025-03-07
Form: 10-K
Item: Item 10
Chunk 0
---
Information required by this Item is hereby incorporated by reference to our Definitive Proxy Statement.

We adopted an Insider Trading and Window Period Policy that governs the purchase, sale and other dispositions of its securities by our directors, officers and employees. We believe the Insider Trading and Window Period Policy is reasonably designed to promote compliance with insider trading laws, rules, and regulations, and any listing standards applicable to us.  A copy of our Insider Trading and Window Period Policy is filed as Exhibit 19.1 to this Annual Report.